logo

For the Inventor, By the Inventor

Franklin, IN, United States of America

Pamela Kay Rockey

This inventor holds 8 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1998-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pamela Kay Rockey. Retrieved from https://idiyas.com/inventor/pamela-kay-rockey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 13(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1998 - 2003)
  • Franklin, IN (US) (2002 - 2003)

Company Filing History:

goldMedal8 out of 4,509 
 
Eli Lilly and Company
 patents

Years Active: 1998-2003

Loading Chart...
8 patents (USPTO):Explore Patents
1. H0002085 - Penicillin binding protein from Streptococcus pneumoniae (2003-10-07),
2. H0002070 - Streptococcus pneumoniae gene sequence for DNA ligase (2003-07-01),
3. H0002023 - Streptococcus pneumoniae sequence GrpE (2002-05-07),
4. H0002021 - Penicillin binding protein from Streptococcus pneumoniae (2002-05-07),
5. 6350866 - Streptococcus pneumoniae gene sequence FtsZ (2002-02-26),
6. 6171834 - Muri protein from Streptococcus pneumoniae (2001-01-09),
7. 5948645 - Biosynthetic gene muri from Streptococcus pneumoniae (1999-09-07),
8. 5789202 - DNA encoding a novel penicillin binding protein from streptococcus (1998-08-04),

Title: Innovations by Pamela Kay Rockey

Introduction

Pamela Kay Rockey is a notable inventor based in Franklin, Indiana. She has made significant contributions to the field of biotechnology, particularly in the development of novel compounds related to bacterial proteins. With a total of eight patents to her name, her work has had a substantial impact on medical research and treatment.

Latest Patents

Among her latest patents is the invention related to a penicillin binding protein from Streptococcus pneumoniae. This invention provides isolated nucleic acid compounds encoding a novel high molecular weight PBP. It also includes vectors and transformed heterologous host cells for expressing the PBP, along with a method for identifying compounds that bind and/or inhibit the enzymatic activity of the PBP. Another significant patent involves the Streptococcus pneumoniae gene sequence for DNA ligase. This invention offers isolated nucleic acid compounds encoding a DNA ligase, vectors, and transformed host cells for expressing the encoded protein, as well as a method for identifying compounds that bind and/or inhibit said protein.

Career Highlights

Pamela is currently employed at Eli Lilly and Company, where she continues to innovate and contribute to the field of pharmaceuticals. Her work at Eli Lilly has allowed her to collaborate with other talented professionals and advance her research.

Collaborations

Some of her notable coworkers include Jo Ann Hoskins and Franklin H. Norris. Their collaborative efforts have further enhanced the research and development initiatives within their organization.

Conclusion

Pamela Kay Rockey's contributions to biotechnology through her patents and work at Eli Lilly and Company highlight her role as a leading inventor in her field. Her innovative research continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…